Principal Investigator on A Randomized, Double-blind, Multicentre, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. Principal Investigator on A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNR. (Janssen)
Preclinical models have examined fibroblast migration and proliferation in BPC-157-treated subjects, with observations of wound closure outcomes reported in experimental settings
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Forman HJ, Zhang H, Rinna A
Head-to-Head Comparison: Cagrilintide vs Semaglutide vs CagriSema Side Effects: What to Expect With Each Option Im not going to sugarcoat the truth or hide behind pharmaceutical marketing language
Based on our studies, we hypothesize that transient treatment with rapamycin, a clinically available drug, offers a simple and rapid metabolic approach to improve current CAR T cell manufacturing practices
Van Campenhout R, Gomes AR, De Groof TWM, Muyldermans S, Devoogdt N, Vinken M
/assets/images/provider/photos/2826746.png)
